Low testosterone alone does not explain why testosterone is low. To understand the possible cause, healthcare providers may also look at luteinizing hormone (LH) and follicle-stimulating hormone (FSH), two hormones that help regulate communication between the brain and testes.
Their pattern can provide useful clues about whether low testosterone is more likely related to the testes themselves or to reduced signalling from the pituitary or hypothalamus. This distinction can help identify primary versus secondary hypogonadism and guide further assessment before testosterone replacement therapy (TRT) is considered.
For men exploring testosterone replacement therapy (TRT) in Canada, LH and FSH are part of the broader clinical picture. No single testosterone, LH or FSH result should be interpreted in isolation.
Topics covered in this article:
LH and FSH are hormones produced by the pituitary gland that help regulate testosterone production and reproductive function.
Luteinizing hormone (LH) primarily signals the Leydig cells in the testes to produce testosterone.
Follicle-stimulating hormone (FSH) works mainly with the Sertoli cells in the testes and plays an important role in sperm production and male fertility.
Both hormones are part of the hypothalamic-pituitary-gonadal axis, often called the HPG axis. This hormonal feedback system connects the brain, pituitary gland and testes:
hypothalamus → pituitary gland → LH and FSH → testes
The hypothalamus releases gonadotropin-releasing hormone, which tells the pituitary to release LH and FSH. The testes then respond by producing testosterone and supporting sperm production.
Because LH, FSH and testosterone are connected through this feedback system, looking at them together can provide more information than looking at testosterone alone.
LH and FSH help determine why testosterone is low and whether the pattern points more toward a testicular problem or reduced signalling from the pituitary or hypothalamus.
A low testosterone result shows that testosterone may be below the expected range, but it does not explain the cause. Measuring LH and FSH can help provide that missing context.
LH is particularly useful for distinguishing primary from secondary hypogonadism. If testosterone is low and LH is elevated, the pattern may suggest that the pituitary is sending a strong signal but the testes are not responding adequately. If testosterone is low and LH is also low or inappropriately normal, the problem may be related to reduced signalling from the pituitary or hypothalamus.
FSH adds more information about testicular and reproductive function, especially because it plays an important role in sperm production. Abnormal FSH results may therefore be particularly relevant when fertility is a concern.
These patterns can help determine whether additional testing is needed before TRT is considered. Depending on the results, a healthcare provider may investigate possible testicular, pituitary, hormonal or reversible causes of low testosterone.
This is why current endocrine guidance recommends measuring LH and FSH when evaluating men with confirmed hypogonadism rather than relying on testosterone alone.
LH, FSH and testosterone are connected through a hormonal feedback system known as the hypothalamic-pituitary-gonadal axis.
A simplified version looks like this:
hypothalamus → pituitary gland → LH and FSH → testes → testosterone and sperm production
The hypothalamus releases gonadotropin-releasing hormone, which signals the pituitary gland to produce LH and FSH.
LH then stimulates the testes to produce testosterone, while FSH helps support sperm production.
Testosterone also sends feedback to the brain. When testosterone levels are adequate, this feedback helps reduce further stimulation from the hypothalamus and pituitary. When testosterone falls, the body may respond by increasing hormonal signalling in an attempt to stimulate more testosterone production.
This is known as negative feedback.
Because of this system, the relationship between testosterone and LH or FSH can be more informative than any one result on its own. For example, low testosterone with high LH suggests a different hormonal pattern from low testosterone with low LH.
Looking at these hormones together can therefore help a healthcare provider understand not only whether testosterone is low, but where the signalling problem may be occurring.
Low testosterone combined with elevated LH generally suggests that the pituitary is sending a strong signal, but the testes are not responding adequately.
This pattern is consistent with primary hypogonadism, also called hypergonadotropic hypogonadism. In this situation, the problem is more likely to be at the level of the testes rather than the pituitary or hypothalamus.
Because testosterone is low, the brain and pituitary attempt to compensate by increasing LH. If LH rises but testosterone remains low, it can suggest impaired testicular function.
Possible causes can include:
However, a high LH result is not a diagnosis by itself. It needs to be interpreted alongside testosterone levels, symptoms, medical history and, when appropriate, other tests.
The American Urological Association similarly notes that elevated LH in the setting of low testosterone points more toward a primary testicular defect.
Low testosterone with low or inappropriately normal LH can suggest secondary hypogonadism, meaning the testes may not be receiving enough hormonal stimulation from the pituitary or hypothalamus.
This is also called central hypogonadism or hypogonadotropic hypogonadism.
In this pattern, the testes may still be capable of producing testosterone, but the hormonal signal telling them to do so is reduced.
Possible contributors can include:
Importantly, LH does not always have to be below the laboratory reference range. If testosterone is clearly low, an LH result that appears “normal” may still be considered inappropriately normal because the expected response would be for LH to rise.
This pattern may lead to further investigation rather than an immediate assumption that TRT is the next step.
For example, the American Urological Association recommends checking prolactin when low testosterone occurs together with low or low-normal LH, since elevated prolactin can suppress the hormonal signalling that supports testosterone production.
The goal is to understand whether an underlying or potentially reversible cause is contributing to low testosterone before deciding on treatment.
Yes. A “normal” LH value can still be inappropriate when testosterone is low.
When testosterone levels fall, the expected physiological response is usually for the pituitary gland to increase LH signalling in an attempt to stimulate more testosterone production.
If testosterone is clearly low but LH remains within the laboratory reference range, that LH level may be considered inappropriately normal for the situation.
This pattern can suggest secondary or central hypogonadism, where the pituitary or hypothalamus is not increasing hormonal signalling as expected.
That is why LH should not be interpreted based on the reference range alone. The result needs to be considered alongside:
A normal LH result therefore does not automatically mean the hormonal signalling system is functioning normally.
High FSH with low testosterone can suggest impaired testicular function, particularly when sperm production is also affected.
FSH plays an important role in supporting sperm production in the testes. When testicular function is impaired, the pituitary may respond by producing more FSH in an effort to increase stimulation.
High FSH may therefore be seen in primary hypogonadism, sometimes alongside elevated LH. However, LH and FSH do not always rise to the same degree because they regulate different aspects of testicular function.
An elevated FSH level may be especially relevant when fertility is a concern because it can point toward impaired sperm production.
The American Urological Association notes that elevated FSH can be associated with abnormal spermatogenesis. In men who are concerned about current or future fertility, additional assessment such as a semen analysis may be appropriate.
As with LH, FSH should not be interpreted in isolation. Testosterone levels, fertility goals, symptoms and the broader clinical picture all help determine what the result may mean.
Low FSH with low testosterone may suggest reduced signalling from the pituitary or hypothalamus and can occur with secondary hypogonadism.
FSH is produced by the pituitary gland, so a low or inappropriately normal FSH level may indicate that the testes are not receiving the expected hormonal stimulation.
This pattern should be interpreted alongside:
Possible contributors can include obesity, chronic illness, certain medications, elevated prolactin and pituitary or hypothalamic conditions.
Some causes may be potentially reversible, so additional testing may be appropriate before deciding on treatment. The goal is to identify whether low testosterone is coming from reduced hormonal signalling rather than assuming the testes themselves are the primary problem.
The main difference is where the problem is occurring. Primary hypogonadism originates mainly at the level of the testes, while secondary hypogonadism involves reduced signalling from the pituitary or hypothalamus.
Pattern | Testosterone | LH/FSH | Possible Source |
Primary hypogonadism | Low | High | Testes |
Secondary hypogonadism | Low | Low or inappropriately normal | Pituitary/hypothalamus |
In primary hypogonadism, the pituitary is usually sending strong signals through LH and FSH, but the testes are not responding adequately. As a result, testosterone remains low while LH and/or FSH rise.
In secondary hypogonadism, the testes may not be receiving enough stimulation because signalling from the pituitary or hypothalamus is reduced. Testosterone is low, while LH and FSH may be low or inappropriately normal.
Not every case fits perfectly into one category. Mixed patterns can occur, particularly when aging, chronic illness, obesity or multiple health conditions are involved.
LH, FSH and testosterone patterns can therefore help identify where the problem may be occurring, but laboratory results alone do not establish the underlying disease. Symptoms, medical history and additional testing may still be needed to determine the cause.
Primary hypogonadism occurs when the testes are not able to produce testosterone adequately despite receiving hormonal signals from the pituitary.
Possible causes include:
Age-related changes can sometimes complicate interpretation because testosterone levels, testicular function and overall health may all change over time.
The key pattern is typically low testosterone with elevated LH and/or FSH, suggesting that the pituitary is increasing stimulation but the testes are not responding adequately.
Secondary hypogonadism occurs when the pituitary or hypothalamus does not provide enough hormonal stimulation to the testes.
Possible contributors include:
In this pattern, testosterone is low while LH and FSH may be low or inappropriately normal.
Importantly, some causes of secondary hypogonadism may be potentially reversible. For example, obesity, medication effects or recovery from certain illnesses can influence testosterone and gonadotropin levels.
That is why the cause should be investigated before assuming that long-term TRT is necessary. Current endocrine guidance emphasizes evaluating potentially reversible contributors to low testosterone, including obesity and certain medications, as part of the assessment process.
Prolactin may be checked when testosterone is low and LH is also low or low-normal because elevated prolactin can suppress the hormonal signalling involved in testosterone production.
High prolactin can interfere with the hypothalamic-pituitary-gonadal axis and reduce stimulation of the testes. This can contribute to a pattern of low testosterone with low or inappropriately normal LH.
The American Urological Association recommends measuring prolactin when low testosterone is accompanied by low or low-normal LH.
If prolactin is elevated, the result may need to be repeated or investigated further depending on the level, symptoms and overall clinical picture.
An elevated prolactin result does not automatically mean a pituitary tumour is present, and not every man with low testosterone needs pituitary imaging. Further evaluation depends on the pattern of results and other symptoms.
Pituitary testing or imaging is not required for every man with low testosterone. It is more likely to be considered when the hormone pattern suggests secondary hypogonadism or when other findings raise concern about pituitary function.
Further evaluation may be considered when there is:
Additional blood tests may be used first to assess other pituitary hormones. In some cases, a healthcare provider may recommend a pituitary MRI.
European Association of Urology guidance recommends pituitary MRI in men with secondary hypogonadism when there is elevated prolactin, symptoms suggesting a pituitary mass, other pituitary hormone deficiencies or severe secondary hypogonadism.
The decision should be individualized. An abnormal LH or FSH result by itself does not automatically mean imaging is necessary.
TRT commonly lowers LH and FSH because external testosterone signals the brain that sufficient testosterone is present, reducing pituitary stimulation of the testes.
This happens through the body’s normal negative feedback system. When testosterone levels rise after starting TRT, the hypothalamus and pituitary reduce the signals that normally stimulate testosterone and sperm production.
As a result:
This suppression is an expected physiological effect of external testosterone and is one reason fertility needs to be discussed before TRT begins.
Because TRT itself can suppress LH and FSH, pre-treatment LH and FSH results can be particularly valuable. Once treatment has started, these hormone levels may no longer reflect the original cause of a man’s low testosterone as clearly.
This is another reason a proper hormonal assessment before TRT can provide useful diagnostic information.
No. Low LH or FSH does not automatically mean you need TRT.
LH and FSH primarily help explain why testosterone may be low. They do not determine TRT eligibility on their own.
TRT is generally considered based on a combination of:
For example, low testosterone with low or inappropriately normal LH may suggest secondary hypogonadism. In that situation, investigating possible causes such as obesity, medications, elevated prolactin, chronic illness or pituitary conditions may be important before deciding on treatment.
Some of these contributors may be reversible or manageable without immediately moving to long-term testosterone therapy.
Fertility also matters because TRT can suppress LH and FSH further and reduce sperm production.
The purpose of LH and FSH testing is therefore not to answer “Do I need TRT?” by itself. It helps answer the more important diagnostic question: “Why is my testosterone low, and what should be evaluated before treatment?”
Fertility matters before TRT because external testosterone can suppress LH and FSH, which may reduce sperm production.
LH and FSH are both involved in normal testicular function. LH supports testosterone production inside the testes, while FSH plays an important role in sperm production.
When TRT is started, the body’s negative feedback system reduces pituitary release of LH and FSH. As these signals fall, intratesticular testosterone can also decrease, which may reduce sperm production and affect fertility.
That is why current and future fertility goals should be discussed before starting TRT.
Baseline FSH can sometimes provide additional information about testicular function, especially when fertility is already a concern. Depending on a man’s goals and medical history, a semen analysis may also be appropriate before treatment.
Men who are actively trying to conceive or want to preserve fertility may need a different treatment approach, so this conversation should happen before TRT is started rather than after sperm production has already been suppressed.
LH and FSH are only part of the evaluation. Other blood tests may be used to confirm testosterone deficiency, look for possible causes and establish a safe baseline before treatment.
These may include:
Not every man needs every test. The exact workup depends on symptoms, testosterone results, LH and FSH patterns, age, medical history and other clinical findings.
The goal of pre-TRT testing is not simply to confirm a low testosterone number. It is to determine whether testosterone deficiency is truly present, what may be causing it and whether TRT is an appropriate treatment option.
Consider speaking to a healthcare provider if you have symptoms of low testosterone along with abnormal hormone results or other concerns that may need further evaluation.
This is especially important if you have:
A healthcare provider can interpret testosterone, LH and FSH together and decide whether repeat testing or additional hormone tests are needed.
One isolated testosterone, LH or FSH result should not be self-interpreted as a diagnosis. Men should also not self-start testosterone based on a single blood test without first understanding why testosterone is low and whether TRT is appropriate.
LH and FSH help determine why testosterone is low. Their pattern can suggest whether the problem is more likely coming from the testes or from reduced signalling by the pituitary or hypothalamus.
Low testosterone with low LH can suggest secondary hypogonadism, where the testes may not be receiving enough stimulation from the pituitary or hypothalamus. Further testing may be needed to identify the cause.
Low testosterone with high LH often suggests primary hypogonadism. This means the pituitary is increasing stimulation, but the testes are not responding adequately.
Yes. A normal-range LH level can sometimes be inappropriately normal when testosterone is clearly low. In that situation, LH may not be rising as much as expected, which can point toward secondary hypogonadism.
Low FSH with low testosterone may occur with secondary hypogonadism and can suggest reduced pituitary or hypothalamic stimulation. The result should be interpreted alongside LH, testosterone and other clinical findings.
High FSH can suggest impaired testicular function, particularly involving sperm production. If fertility is a concern, further assessment such as semen analysis may be appropriate.
Primary hypogonadism occurs when the testes are not producing testosterone adequately despite receiving hormonal stimulation. It often produces a pattern of low testosterone with high LH and/or FSH.
Secondary hypogonadism occurs when signalling from the pituitary or hypothalamus is reduced. Testosterone is low, while LH and FSH may be low or inappropriately normal.
Not necessarily. Low LH can occur with pituitary or hypothalamic conditions, but it can also be associated with obesity, chronic illness, certain medications, elevated prolactin and previous testosterone or anabolic steroid use.
Prolactin may be checked when testosterone is low and LH is low or low-normal because elevated prolactin can suppress reproductive hormone signalling and contribute to secondary hypogonadism.
A pituitary MRI is not needed for every man with low testosterone. It may be considered when secondary hypogonadism is suspected, especially with markedly low testosterone, persistent prolactin elevation, headaches, visual changes or other signs of pituitary dysfunction.
TRT raises circulating testosterone, which sends negative feedback to the hypothalamus and pituitary. The brain then reduces LH and FSH production because it detects that sufficient testosterone is present.
TRT commonly suppresses LH and FSH significantly, although the degree varies between individuals. This reduces natural stimulation of the testes and can affect both testosterone production inside the testes and sperm production.
Yes. LH and FSH are important for normal testicular function and sperm production. Reduced signalling can contribute to impaired fertility, depending on the underlying cause.
No. Low LH does not determine whether TRT is needed. Treatment decisions depend on symptoms, consistently low testosterone, the underlying cause, fertility goals and an individualized clinical assessment.
LH and FSH are commonly used during the evaluation of confirmed testosterone deficiency because they help distinguish primary from secondary hypogonadism. The exact testing required depends on the individual’s symptoms, testosterone results and clinical situation.
Yes. If testosterone is clearly low, LH that falls within the laboratory reference range may still be inappropriately normal because the expected response would be for LH to increase. This can be consistent with secondary hypogonadism and should be interpreted in clinical context.